PMP22 and breast carcinoma: Since then, increased PMP22 expression has also been noted in invasive versus non-invasive mammary carcinoma cell lines [34], in (pre)malignant lesions versus normal pancreatic tissue [35], and in proliferative versus secretory phase endometrium [36].